1-heptadecanoyl-2,3-dioleoyl-sn-glycerol

Metabolite details

Identifier

ANBFFIILUQJIQL-XFGXVVNZSA-N

InChI Key

ANBFFIILUQJIQL-XFGXVVNZSA-N

IUPAC name

3-(heptadecanoyloxy)propane-1,2-diyl (9Z,9'Z)di-octadec-9-enoate

Preferred name

1-heptadecanoyl-2,3-dioleoyl-sn-glycerol

INN name

—

Synonym

1-heptadecanoyl-2,3-bis[(9Z)-octadecenoyl]-sn-glycerol

ChEBI

CHEBI:127309

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
• Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• RNA-Seq and UHPLC-Q-TOF/MS Based Lipidomics Study in Lysiphlebia japonica.
• Lipidomics and RNA-Seq Study of Lipid Regulation in Aphis gossypii parasitized by Lysiphlebia japonica

Observed in differential profiles

• non_COVID_19_healthy_vs_non_critical_COVID_19
• Wild_Type_vs_TMAVA_Treatment
• Control_12h_vs_Toxocara canis_12h
• Larva_vs_Pupa
• Unparasitized_vs_Parasitized